학술논문

Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
Document Type
Article
Source
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH; AUG 18 2022, 22 6, p941-p953, 13p.
Subject
Language
English
ISSN
17448379